The global blister pack pharmaceutical products market growth is anticipated to expand at a CAGR of 6.5% during the forecast period 2021 to 2030. The market is estimated to be driven by rising spending on research and development in the pharma sector coupled with increasing expenditure on healthcare.
Pharmaceutical products such as tablets and capsules are generally pack and seal in variety of blister packaging formats. Blister packaging have brought about a significant change in the way pharmaceuticals tablets and capsules are packed, sealed, and shipped, especially on a large scale. The demand analysis of blister pack pharmaceutical products market is conducted as per drug type, manufacturing process, and end use.
High Preference for Unit Dosing and Small Pack Sizes Supports Sales
Unit dosing leads to higher protection of the primary product from being contaminated, as only the amount required for one time is taken out, while rest of the product remains sealed and secured from external contaminants. Thus, majority of consumers prefer unit dosing. The several benefits offered by unit dosing over bulk packed products have driven manufacturers offering pharmaceuticals products to adopt small pack sizes for their products. High investments in pharmaceuticals have boosted pharmaceutical packaging. The rapid adoption of such unit dosing and small sizing packaging formats, including blister packaging format in the pharmaceutical industry to prevent overconsumption of drugs, is boosting the blister pack pharmaceutical products market.
Inclusion of High-end Technologies Amplifying Sales of Blister Packaging Products in Pharmaceutical Industry
The global blister pack pharmaceutical products market is driven by innovation in product packaging, and consumer convenience is the epicenter. Leading packaging giants operating in the global blister pack pharmaceutical products are constantly incorporating advanced packaging technologies such as thermoforming and cold forming to pack and seal variety of pharmaceutical tablets and capsules, as it fulfils the precise packaging requirement. Furthermore, the demand for oral pharmaceuticals drugs has grown significantly over the past couple of years and projected to witness significant spike in upcoming years. The ability of thermoforming and cold forming packaging technologies to pack tablets and capsules at faster rate coupled with exceptional moisture, oxygen, and light barrier properties ultimately helps pharmaceutical companies to sell and distribute tablets and capsules on a large scale.
Incorporation of such packaging technologies in pharmaceutical packaging, including blister packaging, is anticipated to augment the sales of blister pack pharmaceutical products during the forecast period.
Availability of Alternative Packaging Solutions to Restrict Market Growth
Manufacturers in global blister pack pharmaceutical products market are eager to switch to advancements in packaging formats. Although, major portion of pharmaceuticals capsules and tablets is packed in the blister packaging format; there are adequate alternative packaging formats available in the market. Packaging format, such as bottles, jars, and containers are frequently used in the pharmaceutical industry to pack, seal, and store tablets and capsules. Furthermore, pharmaceutical companies sometimes prefer these packaging solutions to pack and seal tablets and capsules in bulk. The adequate availability of these alternative packaging solutions is considerably impacting the sale of blister pack pharmaceutical products. Development and adoption of such alternative packaging solutions in the pharmaceutical industry restrict the blister pack pharmaceutical products market growth to a certain extent.
The COVID-19 pandemic is expected to have a strong impact on the overall growth trajectory of the global blister pack pharmaceutical products market particularly in the first half of the assessment period. Due to the increasing fear and uncertainty pertaining to the nature of the virus and its mode of transmission in the first two quarters of 2020, players involved in the current pharmaceutical sector were compelled to explore most innovative and safe packaging alternatives. The significant rise in the demand for secondary and primary packaging in a range of drug formats, including capsules, syringes, and bottles, among others, is expected to provide a solid boost to the blister pack pharmaceutical products market amid the ongoing COVID-19 pandemic.
Based on manufacturing process, the thermoforming segment is projected to lead the overall blister pack pharmaceutical products market with more than 3/4th of the market share in 2020. Owing to its ability to pack and seal an extensive range of pharmaceutical tablets and capsules with low manufacturing cost and faster packaging speed, the segment will continue to drive the global blister pack pharmaceutical products market during the forecast period.
As per the VRR analysis, pharmaceuticals is expected to be the most lucrative end-use segment for the blister pack pharmaceutical products market. The same segment is generating consistent demand for blister pack pharmaceutical products such as tablets & capsules and anticipated to hold more than 60% share of total market by the end of 2030.
In terms of market share and revenue generation, the Asia Pacific region is anticipated to dominate the global blister pack pharmaceutical products market. Rising manufacturing output and packaging needs from the pharmaceutical industry in Asian countries is expected to offer substantial opportunities during the forecast period.
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.
The analysts have provided a comprehensive analysis of the competitive landscape of the global blister pack pharmaceutical products market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.
Some of the key players operating in the global blister pack pharmaceutical products market are Pfizer Inc, GlaxoSmithKline plc, Sanofi, Sun Pharmaceutical Industries Ltd, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Cadila Healthcare, etc.
By Drug Type
By Manufacturing Process
By End Use
This report focuses on blister pack pharmaceutical products market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall blister pack pharmaceutical products market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global blister pack pharmaceutical products market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global blister pack pharmaceutical products market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the blister pack pharmaceutical products market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
In this study, the years considered to estimate the market size of blister pack pharmaceutical products are as follows:
The research methodology adopted by analysts for compiling the global blister pack pharmaceutical products market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global blister pack pharmaceutical products market.
The study objectives of this report are: